Bo Lak (002760) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Bo Lak KRW 662, price KRW 996, upside -33.5%, quality 74 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Bo Lak for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 837.00 KRW – 2,632 KRW · fair‑value band 622.70 KRW – 828.10 KRW · the 996.00 KRW price screens above the 662.48 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Bo Lak in your weekly email
Every Wednesday you see whether Bo Lak is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally.
Show more
Bolak Company Limited engages in the manufacture and sale of food ingredients, pharmaceutical raw materials, functional materials, and cosmetic ingredients in South Korea and internationally. The company offers confectionery, beverage, micron, and dairy flavoring products; active pharmaceutical ingredients, such as dry and soft extract powders, fluid extracts, tinctures, natural paclitaxel, docetaxel trihydrates, and Na-CMC and Ca-CMC; health subsidiary foods, including green tea extracts, soy isoflavones, and ginseng extracts; and food coloring products. It also provides gum base products; cosmetic ingredients; fragrances for use in perfumes, cosmetics, hair products, daily supplies, toilet soaps, candles, and industrial products; and other products, such as sweeteners, surfactants, whitening agents, preservatives, antioxidants, abrasives, thickening agents, thickeners, caffeine, and baking powder. Bolak Company Limited was founded in 1959 and is headquartered in Hwaseong-si, South Korea.
Stock analysis
Bo Lak (002760) currently trades at 996.00 KRW, while our model-based Fair Value estimate is 662.48 KRW, implying the stock looks roughly 50.4% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1,042 KRW per share, and 7 of the 23 models we run sit above the 996.00 KRW price.
Bear case: the Earnings-Based group reads lowest at 468.09 KRW, and 16 of the 23 models stay below the price. Evidence for this calculation is low.
Scenario range: 622.70 KRW (bear) to 828.10 KRW (bull), the price of 996.00 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 74/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Bo Lak reported revenue of 50.1B KRW in FY2025 versus 39.8B KRW in FY2021, a compound +6.0%/yr. Reported net income was 2.3B KRW in FY2025, compounding +8.4%/yr from FY2021.
Key figures
Market cap 59.7B KRW (≈ $41.8M) · P/S ratio 1.24 · Dividend yield 0.7% · Net margin 4.7% · Return on equity 5.5% · Return on assets (EBIT) 2.0% · Operating margin 5.0% · Revenue (TTM) 48.3B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 46 out of 100 (medium confidence).
What moves the price
The share trades about 25% below its 52-week high and 19% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at −33%, 002760 screens cheaper than that median.
Fair Value models
Bear 622.70 KRWFair Value 662.48 KRWBull 828.10 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.70/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+5.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+1.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.5%
Start year 2020 (pandemic). Over 10 years: +4.9% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.2%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+30.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+29.3%
Dividend (yield on the price)0.7%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.0% → 4%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−6.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −8.8% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 3/9 measures
Overall it trails its industry peers.
Valuation
Quality Score74 · Top 25%
Fair Value upside−34% · Below median
Profitability
Return on equity (TTM)6% · Below median
Return on assets3% · Below median
Net margin (TTM)5% · Above median
Operating margin (TTM)5% · Below median
Growth and dividend
Revenue growth−14% · Bottom 25%
Dividend yield (TTM)0.7% · Below median
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
P/FCF0.0× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)0· sector 21
PAST (return on equity)22· sector 23
HEALTH (low debt)100· sector 95
DIVIDEND (yield)14· sector 29
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Bo Lak Fair Value". https://www.fairvalue-calculator.com/stock/002760
Frequently asked questions
Is Bo Lak (002760) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 662.48 KRW versus a price of 996.00 KRW, about −33% upside (overvalued).
What is the fair value of 002760?
Our model-based fair value for Bo Lak is 662.48 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 996.00 KRW.
What is the quality score of 002760?
Bo Lak has a Quality Score of 74/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Bo Lak (002760)?
Our model-based price target is the fair value of 662.48 KRW (as of Sep 24, 2026) from 23 valuation models. Cautious scenario 622.70 KRW, optimistic scenario 828.10 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Bo Lak stock forecast for 2026?
Our models put fair value at 662.48 KRW, about −33% upside versus a price of 996.00 KRW (overvalued). Cautious scenario 622.70 KRW, optimistic scenario 828.10 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Bo Lak (002760)?
Bo Lak reported trailing-twelve-month revenue of about 48.3B KRW (latest available figure, as of Sep 24, 2026).
Does Bo Lak pay a dividend?
Bo Lak currently shows a dividend yield of about 0.70% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Bo Lak (002760)?
For today's price to be fair in a discounted-cash-flow model, Bo Lak would have to grow free cash flow by -6.9 % per year for five years (discount rate 8.9 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +5.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 002760 use?
Our models discount Bo Lak at 8.9 %: a base by market capitalisation (nano), damped by beta 0.30, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Bo Lak that is -6.9 % per year a year over ten years, using the same discount rate (8.9 %) and the same formula as our fair value.
How much growth has Bo Lak (002760) delivered so far?
Over the past 5 years revenue at Bo Lak grew +5.5 % a year. The price currently implies -6.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Bo Lak (002760) growing?
The median revenue growth in the sector is +3.3 % a year. That is the yardstick for the growth priced into Bo Lak (-6.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Bo Lak (002760)?
The free-cash-flow yield on the price is 9.90 %: that much free cash flow Bo Lak produces per unit of market value. When it exceeds the discount rate of our models (8.9 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Bo Lak (002760)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Bo Lak it is 662.48 KRW per share (as of Sep 24, 2026), against a price of 996.00 KRW. It is the blended result of 23 valuation models (cash flow, earnings, asset, dividend).
Is Bo Lak stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 002760 trades above its calculated fair value: price 996.00 KRW, fair value 662.48 KRW, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 002760?
No. The price is what the market pays today (996.00 KRW); the fair value is what the company's own numbers justify (662.48 KRW). For Bo Lak the two are 333.52 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Bo Lak worth?
The market values Bo Lak at about 59.7B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 996.00 KRW; our models calculate a fair value of 662.48 KRW per share.
What do the bullish and bearish scenarios say about 002760?
Our models span a range for Bo Lak: cautious scenario 622.70 KRW, base 662.48 KRW, optimistic 828.10 KRW per share (as of Sep 24, 2026, price 996.00 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Bo Lak (002760)?
Balance-sheet figures for Bo Lak (as of Sep 24, 2026): return on equity 5.5%. They feed the Quality Score of 74/100, which measures business quality independently of the share price.
How far is 002760 from its 52-week high?
Bo Lak trades at 996.00 KRW, about 25% below its 52-week high of 1,323 KRW and 19% above the low of 837.00 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 662.48 KRW is for.
Which stocks are comparable to Bo Lak?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Bo Lak stock attractive at the current price?
The data as of Sep 24, 2026: price 996.00 KRW, calculated fair value 662.48 KRW (−33%), Quality Score 74/100, from 23 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 002760 calculated?
We run Bo Lak through 23 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 662.48 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Bo Lak itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Bo Lak (002760)?
The closing price on Sep 23, 2026 was 996.00 KRW. Our model-based fair value is 662.48 KRW, about −33% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Bo Lak right now?
A high-quality business (quality 74/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety. The price sits above even our optimistic bull case (828.10 KRW). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of Bo Lak
How large is the market capitalisation of Bo Lak (002760)?
The market capitalisation of Bo Lak is 59.7B KRW (≈ $41.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Bo Lak (002760)?
The price-to-sales ratio of Bo Lak is 1.24 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Bo Lak (002760)?
The dividend yield of Bo Lak is 0.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Bo Lak (002760)?
The net margin of Bo Lak is 4.7% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Bo Lak (002760)?
The return on equity (ROE) of Bo Lak is 5.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Bo Lak (002760)?
On an EBIT basis the return on assets of Bo Lak is 2.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Bo Lak (002760)?
The operating margin of Bo Lak is 5.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Bo Lak (002760)?
Revenue at Bo Lak is growing −14.1% versus a year earlier (3y avg +1.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Bo Lak (002760)?
Earnings per share at Bo Lak are growing +126% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Bo Lak (002760) carry?
The net debt of Bo Lak is 1.3B KRW (fiscal year 2021, ≈ 0.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Bo Lak in the live analysis
One click puts Bo Lak on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
